Recursion Pharmaceuticals

RXRX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$35.5M

Previous year: $4.55M

+681.7%

EPS

-$0.21

Previous year: -$0.53

-60.4%

R&D Expenses

$95.9M

Previous year: $98.3M

-2.4%

G&A Expenses

$33.7M

Previous year: $77.2M

-56.4%

Cash, Cash Equivalents and Restricted Cash

Previous year: $1.45B

+1.8%

Loading...

Recursion Pharmaceuticals

Unlock previous datapoints

Upgrade

Recursion Pharmaceuticals

Unlock previous datapoints

Upgrade

Recursion Pharmaceuticals Revenue by Segment

Revenue by Segment

Collaboration Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Grant Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.64B

P/E Ratio

-2.10

Sector

N/A

Industry

N/A

52-Week High

$6.78

52-Week Low

$2.84

R&D Expenses

$95.9M

G&A Expenses

$33.7M

Cash, Cash Equivalents and Restricted Cash

$754M

Products

Get in Touch

Resources

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Recursion Pharmaceuticals Revenue by Segment

Revenue by Segment

Collaboration Revenue

Grant Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics